Press Releases
January 10, 2026
Attorney General Tong Announces Agreement with Hartford Healthcare to Help Protect Against Cost Increases and Preserve Professional Freedom for Physicians in Acquisition of Prospect Medical's Manchester Memorial and Rockville General Hospitals
Gov't Institution
The Office of Attorney General Connecticut
Owner: American Government
January 10, 2026
Tourism Transformation: Hospitality Visionary Invests in College of Charleston
Indeterminate
GlobeNewswire, Inc.
January 10, 2026
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Study examines declines in availability of hospital-based obstetric services by county
Neutral
American Hospital Association
January 9, 2026
Organ Recovery Pack Correction: AVID Medical Issues Correction for Medical Convenience and Organ Recovery Kits
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
January 9, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Organ Recovery Pack Correction: AVID Medical Issues Correction for Medical Convenience and Organ Recovery Kits
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
January 8, 2026
Hospital Benefits to Communities Far Outweigh Tax Exemptions: A Closer Look at the Numbers
Neutral
American Hospital Association
January 9, 2026
Importing Liquid Cough and Cold Medicine from India
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
January 9, 2026
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Minister Dean Macpherson confirms termination of lease agreement with Medicare 24 Tshwane
Gov't Institution
South African Government
Owner: South African Government
January 9, 2026
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
January 9, 2026
Avance Clinical to Showcase New Early Phase Center of Excellence at Biotech Showcase 2026
Indeterminate
GlobeNewswire, Inc.
January 9, 2026
Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine
Indeterminate
GlobeNewswire, Inc.